Hospital clusters of invasive Group B Streptococcal disease: A systematic review.


Journal

The Journal of infection
ISSN: 1532-2742
Titre abrégé: J Infect
Pays: England
ID NLM: 7908424

Informations de publication

Date de publication:
12 2019
Historique:
received: 04 11 2019
accepted: 08 11 2019
pubmed: 17 11 2019
medline: 16 7 2020
entrez: 17 11 2019
Statut: ppublish

Résumé

To characterize outbreaks of invasive Group B Streptococcal (iGBS) disease in hospitals. Systematic review using electronic databases to identify studies describing iGBS outbreaks/clusters or cross-infection/acquisition in healthcare settings where 'cluster' was defined as ≥2 linked cases. PROSPERO CRD42018096297. Twenty-five references were included describing 30 hospital clusters (26 neonatal, 4 adult) in 11 countries from 1966 to 2019. Cross-infection between unrelated neonates was reported in 19 clusters involving an early-onset (<7 days of life; n = 3), late-onset (7-90 days; n = 13) index case or colonized infant (n = 3) followed by one or more late-onset cases (median serial interval 9 days (IQR 3-17, range 0-50 days, n = 45)); linkage was determined by phage typing in 3 clusters, PFGE/MLST/PCR in 8, WGS in 4, non-molecular methods in 4. Postulated routes of transmission in neonatal clusters were via clinical personnel and equipment, particularly during periods of crowding and high patient-to-nurse ratio. Of 4 adult clusters, one was attributed to droplet spread between respiratory cases, one to handling of haemodialysis catheters and two unspecified. Long intervals between cases were identified in most of the clusters, a characteristic which potentially hinders detection of GBS hospital outbreaks without enhanced surveillance supported by genomics.

Identifiants

pubmed: 31733233
pii: S0163-4453(19)30346-9
doi: 10.1016/j.jinf.2019.11.008
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

521-527

Subventions

Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S016570/1
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019. Published by Elsevier Ltd.

Auteurs

Simon M Collin (SM)

Healthcare-Associated Infection and Antimicrobial Resistance Division, National Infection Service, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK. Electronic address: simon.collin@phe.gov.uk.

Peter Lamb (P)

Healthcare-Associated Infection and Antimicrobial Resistance Division, National Infection Service, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.

Elita Jauneikaite (E)

Department of Infectious Disease Epidemiology, School of Public Health, Imperial College, London, UK; NIHR Health Protection Research Unit in Healthcare-Associated Infections and Antimicrobial Resistance, Imperial College, London, UK.

Kirsty Le Doare (K)

Paediatric Infectious Diseases Research Group, St George's University of London, London, UK; MRC/Uganda Virus Research Institute (UVRI) and London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda; Pathogen Immunity Group, Public Health England, Porton Down, UK.

Roberta Creti (R)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Alberto Berardi (A)

Neonatal Intensive Care Unit, Maternal and Child Department, University Hospital, Modena, Italy.

Paul T Heath (PT)

Paediatric Infectious Diseases Research Group, St George's University of London, London, UK.

Shiranee Sriskandan (S)

NIHR Health Protection Research Unit in Healthcare-Associated Infections and Antimicrobial Resistance, Imperial College, London, UK; MRC Centre for Molecular Bacteriology & Infection, Imperial College, London, UK.

Theresa Lamagni (T)

Healthcare-Associated Infection and Antimicrobial Resistance Division, National Infection Service, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK; NIHR Health Protection Research Unit in Healthcare-Associated Infections and Antimicrobial Resistance, Imperial College, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH